This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Safety Remove Sativa Remove Seminar Related Topics
Terpenes Hash Collective Pets Concentrates Data Extraction Clinical Trials Cannabinoids Epilepsy More Related Topics >
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. upcoming seminars). Framings that more often carried a negative tone were related to poor evidence and safety issues.

Research and Development 52
Research and Development Medicine Access Media 52
article thumbnail

Introducing AJEM- The American Jnl Of Endocannabinoid Medicine – Read Issue 1 For FREE

Cannabis Law Report

DECEMBER 8, 2019

Edited by renowned endocannabinoid researcher, Jahan Marcu, PhD, AJEM’s inaugural issue was published last month in conjunction with a medical education seminar put on by Havas at Columbia University. United States Food and Drug Administration Center for Food Safety and Applied Nutrition. Cannabis Law J. September 2017.

Medicine 59
Medicine Research and Development Food Cannabinoids 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024